- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1743-422X
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Rapid detection of anti-Vaccinia virus neutralizing antibodies ; volume:8 ; number:1 ; day:25 ; month:3 ; year:2011 ; pages:1-7 ; date:12.2011
Virology journal ; 8, Heft 1 (25.3.2011), 1-7, 12.2011
- Creator
-
Kramski, Marit
- Contributor
-
Drozd, Anna
Lichtfuss, Gregor F.
Dabrowski, Piotr W.
Ellerbrok, Heinz
SpringerLink (Online service)
- DOI
-
10.1186/1743-422X-8-139
- URN
-
urn:nbn:de:1111-201605014853
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:53 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Kramski, Marit
- Drozd, Anna
- Lichtfuss, Gregor F.
- Dabrowski, Piotr W.
- Ellerbrok, Heinz
- SpringerLink (Online service)
Other Objects (12)
Neutralizing antibodies against porcine epidemic diarrhea virus block virus attachment and internalization
Zika Virus Baculovirus-Expressed Virus-Like Particles Induce Neutralizing Antibodies in Mice
Analysis of Zika virus neutralizing antibodies in normal healthy Thais
Facile quantitative diagnostic testing for neutralizing antibodies against Chikungunya virus
Engineering the vaccinia virus L1 protein for increased neutralizing antibody response after DNA immunization
A focus reduction neutralization assay for hepatitis C virus neutralizing antibodies
Broadly Neutralizing Antibodies as Treatment: Effects on Virus and Immune System
Glycoprotein N of Human Cytomegalovirus Protects the Virus from Neutralizing Antibodies
Measles virus glycoprotein-based lentiviral targeting vectors that avoid neutralizing antibodies
Antigene des Vaccinia Virus
Neutralizing and non-neutralizing monoclonal antibodies against dengue virus E protein derived from a naturally infected patient
Quantitation of SARS-CoV-2 neutralizing antibodies using virus-like particles
Neutralizing antibodies against porcine epidemic diarrhea virus block virus attachment and internalization
Zika Virus Baculovirus-Expressed Virus-Like Particles Induce Neutralizing Antibodies in Mice
Analysis of Zika virus neutralizing antibodies in normal healthy Thais
Facile quantitative diagnostic testing for neutralizing antibodies against Chikungunya virus
Engineering the vaccinia virus L1 protein for increased neutralizing antibody response after DNA immunization
A focus reduction neutralization assay for hepatitis C virus neutralizing antibodies
Broadly Neutralizing Antibodies as Treatment: Effects on Virus and Immune System
Glycoprotein N of Human Cytomegalovirus Protects the Virus from Neutralizing Antibodies
Measles virus glycoprotein-based lentiviral targeting vectors that avoid neutralizing antibodies
Antigene des Vaccinia Virus
Neutralizing and non-neutralizing monoclonal antibodies against dengue virus E protein derived from a naturally infected patient
Quantitation of SARS-CoV-2 neutralizing antibodies using virus-like particles
Neutralizing antibodies against porcine epidemic diarrhea virus block virus attachment and internalization
Zika Virus Baculovirus-Expressed Virus-Like Particles Induce Neutralizing Antibodies in Mice
Analysis of Zika virus neutralizing antibodies in normal healthy Thais
Facile quantitative diagnostic testing for neutralizing antibodies against Chikungunya virus
Engineering the vaccinia virus L1 protein for increased neutralizing antibody response after DNA immunization
A focus reduction neutralization assay for hepatitis C virus neutralizing antibodies
Broadly Neutralizing Antibodies as Treatment: Effects on Virus and Immune System
Glycoprotein N of Human Cytomegalovirus Protects the Virus from Neutralizing Antibodies
Measles virus glycoprotein-based lentiviral targeting vectors that avoid neutralizing antibodies
Antigene des Vaccinia Virus
Neutralizing and non-neutralizing monoclonal antibodies against dengue virus E protein derived from a naturally infected patient